Beijing Wandong Medical Technology Co.,Ltd. (SHA:600055)
China · Delayed Price · Currency is CNY 12.25
-0.41 (-3.24%)
Jun 4, 2026, 3:00 PM CST
SHA:600055 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,612 | 10,954 | 10,616 | 12,008 | 13,738 | 12,759 | |
Market Cap Growth | -28.99% | 3.18% | -11.59% | -12.59% | 7.67% | 135.28% |
Enterprise Value | 5,783 | 7,966 | 7,371 | 8,825 | 10,643 | 11,775 |
Last Close Price | 12.25 | 15.58 | 14.99 | 16.80 | 19.11 | 23.20 |
PE Ratio | - | - | 67.47 | 63.69 | 78.34 | 69.65 |
Forward PE | - | 48.42 | 48.42 | 48.42 | 47.66 | 62.66 |
PS Ratio | 6.24 | 8.13 | 6.96 | 9.71 | 12.25 | 11.04 |
PB Ratio | 1.89 | 2.40 | 2.18 | 2.49 | 2.92 | 5.10 |
P/TBV Ratio | 1.95 | 2.47 | 2.24 | 2.56 | 3.00 | 5.38 |
P/FCF Ratio | - | - | 59.10 | 62.84 | 80.17 | 163.85 |
P/OCF Ratio | - | - | 48.64 | 57.67 | 74.10 | 142.21 |
EV/Sales Ratio | 4.19 | 5.91 | 4.84 | 7.14 | 9.49 | 10.18 |
EV/EBITDA Ratio | - | - | 72.61 | 78.71 | 68.13 | 53.23 |
EV/EBIT Ratio | - | - | 110.18 | 111.63 | 85.20 | 63.07 |
EV/FCF Ratio | -16.50 | - | 41.03 | 46.18 | 62.11 | 151.20 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 |
Debt / EBITDA Ratio | - | - | 0.25 | 0.15 | 0.14 | 0.08 |
Debt / FCF Ratio | - | - | 0.15 | 0.09 | 0.13 | 0.24 |
Net Debt / Equity Ratio | -0.65 | -0.71 | -0.73 | -0.71 | -0.70 | -0.44 |
Net Debt / EBITDA Ratio | 7.86 | 9.75 | -35.07 | -30.53 | -21.25 | -5.03 |
Net Debt / FCF Ratio | 8.39 | 9.23 | -19.82 | -17.91 | -19.37 | -14.30 |
Asset Turnover | 0.26 | 0.24 | 0.28 | 0.23 | 0.28 | 0.40 |
Inventory Turnover | 3.00 | 2.37 | 3.29 | 2.23 | 2.75 | 2.89 |
Quick Ratio | 4.65 | 3.43 | 7.87 | 7.59 | 7.98 | 4.94 |
Current Ratio | 5.41 | 4.01 | 8.32 | 8.38 | 8.67 | 5.67 |
Return on Equity (ROE) | -5.88% | -4.82% | 3.27% | 4.00% | 4.77% | 7.38% |
Return on Assets (ROA) | -4.80% | -4.13% | 0.77% | 0.93% | 1.92% | 4.07% |
Return on Invested Capital (ROIC) | -28.17% | -28.05% | 4.68% | 5.07% | 8.03% | 12.43% |
Return on Capital Employed (ROCE) | -9.00% | -8.10% | 1.40% | 1.60% | 2.60% | 7.30% |
Earnings Yield | -3.24% | -2.08% | 1.48% | 1.57% | 1.28% | 1.44% |
FCF Yield | -4.07% | -3.20% | 1.69% | 1.59% | 1.25% | 0.61% |
Dividend Yield | 1.06% | - | 0.87% | 0.77% | 0.63% | 0.43% |
Payout Ratio | - | - | 58.09% | 44.75% | 40.09% | 38.03% |
Buyback Yield / Dilution | -0.06% | -0.12% | -0.22% | -6.31% | -23.08% | -0.01% |
Total Shareholder Return | 1.01% | -0.12% | 0.64% | -5.54% | -22.45% | 0.42% |